Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Neoplasm Metastasis 2Zollinger-Ellison Syndrome 1Vomiting 1Stomach Neoplasms 1Spinal Cord Compression 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Neoplasms 1Ototoxicity 1Osteosarcoma 1Helicobacter Infections 1Gastritis, Atrophic 1Gastrinoma 1Duodenal Neoplasms 1Delayed Bleeding 1Colorectal Neoplasms 1Breast Neoplasms 1Advanced Solid Tumours 1

Interventions

Temozolomide 2Omeprazole 2Lansoprazole 2Esomeprazole 2Capecitabine 2veliparib 1pazopanib 1cixutumumab 1YF 476 1Streptozocin 1Salts 1Pantoprazole 1Octreotide 1Interferons 1Fluorouracil 1Everolimus 1Doxorubicin 1Dexlansoprazole 1Clopidogrel 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Zollinger-Ellison Syndrome × Pantoprazole × Clear all
NCT00001191 2017-07-02

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Zollinger-Ellison Syndrome, Gastrinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡